Trial Profile
To describe the regulatory B cells and T cells and T helper17 lymphocytes before and under treatment with Abatacept and Rituximab in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2017
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Rituximab
- Indications Rheumatoid arthritis
- Focus Biomarker; Therapeutic Use
- 21 Nov 2017 New trial record